Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",49330,301,0.93 [0.72-1.19],0.5507453420085207
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",51109,397,1.27 [1.03-1.57],0.0253678427690949
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",50581,2745,1.05 [0.97-1.14],0.2024711338382261
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Candidiasis,51146,848,1.13 [0.97-1.30],0.1114956766390887
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,49601,6982,1.08 [1.03-1.14],0.0026858790051171
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),49790,6385,1.11 [1.05-1.17],0.000103935874141
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,50643,2425,1.20 [1.10-1.30],5.246471637994303e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,50965,174,1.45 [1.06-1.99],0.0199244085693399
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,47057,1938,1.20 [1.09-1.32],0.0002603390019758
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,45469,2199,1.22 [1.12-1.34],1.3139760977600069e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,45212,514,1.18 [0.98-1.43],0.0813448614481414
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,35911,3951,1.07 [0.99-1.14],0.071392600599032
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,44892,775,1.39 [1.20-1.62],2.023719641258022e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,51076,2858,1.18 [1.09-1.27],5.9012987553018165e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Mycoses,51303,1005,1.06 [0.93-1.21],0.3809144511090376
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,49681,1845,1.06 [0.96-1.17],0.2741557276555901
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,51170,2141,1.14 [1.04-1.25],0.0057288457700403
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,48617,399,1.28 [1.03-1.58],0.0228531393287471
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,51405,97,1.43 [0.94-2.20],0.0983206159467109
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other septicaemia,50898,1869,1.17 [1.06-1.29],0.0015951731815545
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,50946,155,1.11 [0.79-1.55],0.5529171109014848
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other viral diseases,51249,321,1.30 [1.02-1.64],0.0312810755828718
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",51210,282,1.32 [1.03-1.71],0.0295459892477562
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,48665,829,1.18 [1.02-1.37],0.0253026122000313
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,48383,547,1.08 [0.90-1.30],0.4006462070093339
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,48436,218,1.23 [0.93-1.64],0.1510880270582897
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,51364,107,1.54 [1.04-2.29],0.0309238078400978
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,51271,304,1.04 [0.81-1.33],0.7664017561212054
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Viral warts,51067,100,1.20 [0.78-1.84],0.3963870609047156
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],51096,129,1.02 [0.70-1.48],0.9353215762379118
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign lipomatous neoplasm,50822,581,0.87 [0.73-1.05],0.1408729232202669
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,51232,117,0.83 [0.55-1.24],0.3600511311565264
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,51193,122,1.05 [0.71-1.55],0.8058325304121983
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23613,125,0.81 [0.55-1.20],0.2889207251594672
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",50740,2885,0.93 [0.86-1.01],0.0848342894561411
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm of meninges,51378,115,0.86 [0.58-1.29],0.4780717933127697
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,51273,130,1.05 [0.72-1.53],0.7863704924439581
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,51356,216,1.33 [1.00-1.76],0.0515044379094882
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm of ovary,27660,178,1.31 [0.95-1.80],0.0980161080618576
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Ascending colon,51359,724,0.96 [0.82-1.12],0.5986655656229574
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Caecum,51359,593,0.80 [0.67-0.96],0.0137903601726205
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",51187,146,0.94 [0.66-1.33],0.709801810020731
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Descending colon,51353,431,0.70 [0.57-0.86],0.0008706553261297
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Rectum,51275,704,0.93 [0.79-1.09],0.3820354616080996
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,51172,1236,0.96 [0.84-1.08],0.4648403568688841
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Transverse colon,51341,860,0.82 [0.70-0.95],0.0066994711809691
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Carcinoma in situ of breast,22467,140,1.13 [0.78-1.64],0.5118622924343477
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22557,169,1.16 [0.83-1.62],0.3953544656939957
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",40909,102,0.77 [0.50-1.19],0.2332921576039947
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",40945,138,1.28 [0.89-1.85],0.1820495412091928
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",51306,239,1.04 [0.78-1.37],0.8026583287737393
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Haemangioma, any site",51307,235,1.06 [0.80-1.41],0.6876875962548263
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Leiomyoma of uterus,26743,585,0.85 [0.71-1.02],0.0805817100098179
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Lung cancer and mesothelioma,35646,654,0.66 [0.56-0.78],1.815798704408651e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Lymphoid leukaemia,40909,102,0.79 [0.51-1.23],0.2973465224478586
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",41180,373,0.95 [0.75-1.20],0.6601523260928166
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",41209,402,1.00 [0.80-1.24],0.993031010944902
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",22694,189,1.17 [0.85-1.60],0.3411155705275283
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",40973,166,1.23 [0.89-1.72],0.213695840171603
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",41021,214,1.16 [0.86-1.55],0.3285656947004883
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",41003,196,1.09 [0.80-1.48],0.5903232183575595
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22649,144,1.42 [1.00-2.02],0.0513143172271165
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",40994,187,0.91 [0.66-1.25],0.5603256825461418
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",19691,1389,0.93 [0.83-1.05],0.224556829244731
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",41033,226,0.80 [0.59-1.07],0.1268956003425146
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",40956,149,0.85 [0.60-1.21],0.3629314059737065
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,41019,212,1.15 [0.85-1.56],0.3509431575526597
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Melanocytic naevi,51009,399,0.97 [0.78-1.21],0.7966762897995736
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Melanocytic naevi of trunk,51324,175,0.78 [0.56-1.09],0.1471698059430172
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Melanoma in situ,40875,162,1.02 [0.72-1.45],0.8901515097049624
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",40989,182,1.09 [0.79-1.51],0.5838207595837306
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",41128,321,1.06 [0.83-1.35],0.6606979598337552
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",41249,442,0.65 [0.53-0.79],2.9045867752097256e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",41006,199,1.11 [0.81-1.50],0.5153946026750689
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Other benign neoplasms of skin,51042,305,0.87 [0.68-1.12],0.2762233875417265
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",42957,2150,1.10 [1.00-1.21],0.0538252331184122
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",43075,2268,1.10 [1.00-1.21],0.0398066917844791
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,50817,687,1.06 [0.90-1.24],0.5173477704455073
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,47616,225,3.70 [2.96-4.62],1.5488561308690667e-30
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,50275,145,0.93 [0.65-1.33],0.7086357128778327
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,49817,5801,1.15 [1.08-1.21],2.108418252322234e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,48460,96,1.45 [0.95-2.21],0.0874977697895559
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,50569,102,0.84 [0.55-1.29],0.4340846020304288
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,50429,3038,1.28 [1.19-1.39],1.8854205866794624e-10
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,50427,3036,1.28 [1.19-1.39],1.6980205779900556e-10
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,47567,176,1.54 [1.12-2.13],0.0076829793290471
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,50752,2388,1.23 [1.13-1.35],1.8298139192697063e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,50695,228,1.31 [0.99-1.74],0.0582824431234789
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,50258,128,0.88 [0.60-1.28],0.4942693658937773
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,50248,118,1.14 [0.78-1.69],0.4946222378390663
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,51022,555,1.24 [1.03-1.48],0.0202603568191556
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,51192,112,0.47 [0.31-0.71],0.0002872893967258
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",50927,460,1.31 [1.07-1.59],0.0080083682300161
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,48579,215,1.24 [0.93-1.66],0.1388879434194063
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,39752,633,1.30 [1.09-1.54],0.0027311709969687
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,47928,232,0.45 [0.34-0.60],8.113028824649004e-08
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,47952,256,0.34 [0.26-0.45],5.395496449526866e-15
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,39225,106,0.61 [0.40-0.95],0.0270534621939595
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,47732,134,0.77 [0.53-1.12],0.1681901478328368
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,46597,472,1.14 [0.94-1.39],0.1823057123219205
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",50459,1124,0.99 [0.87-1.13],0.9128310516457884
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,49867,532,0.81 [0.67-0.97],0.0253178168370468
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,49589,254,0.73 [0.55-0.96],0.0222637676547003
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,50699,3101,0.97 [0.90-1.05],0.4671855020611233
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,44788,3007,0.96 [0.89-1.04],0.340161175437903
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",39254,135,1.41 [0.97-2.04],0.0723484685076121
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",47395,159,1.52 [1.09-2.12],0.0141491892606788
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,39677,558,1.18 [0.98-1.41],0.0855452459368601
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,39242,123,0.84 [0.56-1.26],0.4033895425630048
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,46157,7038,1.01 [0.96-1.07],0.675907792761895
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,39511,392,1.38 [1.11-1.72],0.003360660624581
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,40230,1111,1.17 [1.02-1.33],0.0202805706456706
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,51240,653,1.54 [1.31-1.82],1.9221762577447414e-07
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,50864,277,2.24 [1.77-2.85],3.533375093594435e-11
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,39371,252,0.99 [0.75-1.31],0.9342735931108852
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",39240,121,1.42 [0.96-2.10],0.0791248121067921
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,50324,3088,1.17 [1.08-1.26],9.644199660678183e-05
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,39638,519,2.19 [1.83-2.61],7.694197885123201e-18
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,39716,597,2.22 [1.88-2.62],1.4642898360361481e-21
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",40383,1264,1.02 [0.90-1.15],0.7496583832209069
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,39358,239,1.01 [0.76-1.34],0.9332781611620202
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,50847,260,2.37 [1.86-3.03],3.993469893293411e-12
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,40328,1209,1.09 [0.96-1.24],0.1728647537163776
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,40079,960,0.92 [0.80-1.06],0.2316877133881693
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,46262,137,1.56 [1.09-2.23],0.0144529458891793
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,49053,9934,1.02 [0.97-1.06],0.4436593756402917
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,47334,98,1.32 [0.86-2.01],0.2036404919112067
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,47345,109,1.29 [0.85-1.95],0.2256563321714322
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,51031,3876,0.95 [0.89-1.02],0.1663481067306469
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",51033,3871,0.95 [0.89-1.02],0.1633942721180967
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,47339,103,1.33 [0.88-2.01],0.1788489611268542
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,50719,2396,0.99 [0.91-1.08],0.834289759686875
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",42285,3166,1.15 [1.07-1.24],0.0002488772444443
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,51380,451,1.46 [1.21-1.77],0.0001038170894607
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,49500,165,1.12 [0.81-1.56],0.4857074386892909
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,48532,209,0.91 [0.67-1.22],0.5269015438757295
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,48604,281,0.90 [0.70-1.16],0.4223181134159132
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",39457,338,1.15 [0.90-1.46],0.2686901066102051
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,46779,312,1.23 [0.97-1.56],0.0834365517099711
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,4222,170,1.58 [1.16-2.15],0.0033514339144537
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,4499,502,1.07 [0.89-1.29],0.447345130226267
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,46590,123,1.10 [0.75-1.62],0.6105594163547735
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,4162,113,3.90 [2.79-5.44],1.201095034833089e-15
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,50121,3654,0.87 [0.81-0.93],7.17754359242814e-05
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,50040,705,0.88 [0.75-1.03],0.1151736924338219
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,46858,733,1.06 [0.91-1.24],0.4376614187135931
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,40659,1540,1.16 [1.04-1.29],0.0082884711235238
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",51179,485,1.04 [0.86-1.26],0.7016224392971423
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),49149,327,0.94 [0.74-1.19],0.5959178246191452
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Angina pectoris,46941,2382,1.07 [0.98-1.17],0.1270491106400763
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Aortic aneurysm,49304,482,1.06 [0.87-1.29],0.5486065044880251
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,48938,116,1.23 [0.83-1.83],0.2967111485237238
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",49223,401,1.24 [1.00-1.53],0.0482251353233942
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,31890,3817,1.12 [1.04-1.20],0.0021042363837588
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,AV-block,43297,868,1.21 [1.05-1.41],0.0107792374469073
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",51285,840,1.33 [1.15-1.54],0.0001334279518073
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Cardiac arrest,28452,379,1.49 [1.19-1.86],0.0005182731480503
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Cardiomyopathy,42767,338,1.45 [1.14-1.83],0.0020457554136464
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",42619,190,1.34 [0.98-1.84],0.0653324539388957
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,51401,102,1.62 [1.09-2.42],0.0177041844338368
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Conduction disorders,44536,2107,1.23 [1.12-1.35],1.757525225874046e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,48669,4145,1.10 [1.03-1.17],0.0055056831441195
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,44864,15071,0.92 [0.89-0.96],2.471820625262631e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,DVT of lower extremities,48633,523,1.10 [0.91-1.33],0.3100280666292087
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Endocarditis,42575,146,1.67 [1.17-2.37],0.004267128547454
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Heart failure, strict",50996,2191,1.23 [1.12-1.35],6.116336516842622e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Hypertension,46685,12945,0.90 [0.87-0.94],3.956976392870569e-07
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Hypertension, essential",46720,12980,0.91 [0.88-0.95],2.884825899172629e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Hypertension, portal",51059,158,1.34 [0.96-1.86],0.086354141533114
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",34090,350,2.40 [1.94-2.97],7.027111983094704e-16
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,34014,274,5.19 [4.39-6.13],5.489963668861108e-84
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Hypotension,51114,2365,1.27 [1.17-1.39],6.166553106014115e-08
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,49569,213,0.94 [0.70-1.26],0.6589092417190692
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",49014,4455,1.08 [1.01-1.15],0.0272776969251722
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",50656,1115,1.14 [1.01-1.30],0.0412062471629813
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Left bundle-branch block,43150,721,1.43 [1.22-1.68],1.0891185535532296e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,50453,1670,1.06 [0.96-1.18],0.2415121387682227
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",45970,1411,1.14 [1.01-1.27],0.0300116009828008
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",51217,308,1.21 [0.95-1.54],0.1147012135947383
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",51347,614,1.10 [0.93-1.31],0.2771921504270733
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Oesophageal varices,48221,111,1.19 [0.80-1.78],0.3944986963244844
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other aneurysm,48980,158,1.00 [0.71-1.41],0.99085261021021
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other arrhythmias,43270,841,1.23 [1.05-1.43],0.007884510904048
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,49022,200,1.17 [0.87-1.59],0.3042883254909837
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,49302,480,1.35 [1.11-1.64],0.0022442598566287
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,42779,350,1.29 [1.02-1.63],0.0305981644283724
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other disorders of veins,48304,194,1.18 [0.87-1.59],0.2955827309343602
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,48206,96,1.21 [0.79-1.86],0.3872565262228261
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,48544,127,1.00 [0.68-1.46],0.9826020438710338
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,48383,273,1.14 [0.88-1.47],0.3213223311808737
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,44501,2072,1.28 [1.16-1.40],3.683903848840352e-07
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,48857,108,1.58 [1.06-2.36],0.0240796737374621
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,49901,1079,1.18 [1.03-1.34],0.0144479532012238
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,50185,688,1.44 [1.23-1.68],5.547716462622208e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",49633,1216,1.05 [0.93-1.18],0.4723930668019198
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,28747,674,1.24 [1.04-1.47],0.0153962811702473
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Peripheral artery disease,49568,806,1.29 [1.11-1.49],0.0009155996089595
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),48794,684,1.09 [0.93-1.29],0.2992413967373108
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Pulmonary embolism,50436,939,1.05 [0.91-1.21],0.5106281846671816
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,51265,1311,1.29 [1.15-1.45],1.588110254064975e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Right bundle-branch block,43128,699,1.21 [1.03-1.42],0.0239609884532559
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Secondary right heart disease,50175,678,1.40 [1.20-1.64],2.53825802162542e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,48807,390,1.16 [0.93-1.43],0.17998014146433
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",50633,1277,1.11 [0.98-1.25],0.0928321541884399
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",50591,1355,1.09 [0.97-1.23],0.1280339687947834
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,49511,119,0.92 [0.62-1.37],0.6879607902635582
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,48985,163,1.58 [1.12-2.21],0.0082707021624668
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Transient ischemic attack,50012,471,1.24 [1.02-1.51],0.0330035375784407
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,49297,514,0.96 [0.79-1.15],0.6462447271039049
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Varicose veins,48958,848,1.18 [1.02-1.37],0.0258544843524335
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,48853,170,0.82 [0.58-1.14],0.2398956891890186
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Venous thromboembolism,50952,1484,1.07 [0.96-1.19],0.2506951609564469
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",51161,717,0.49 [0.42-0.58],2.805299748372347e-17
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",44971,2835,0.99 [0.91-1.07],0.7321149728581415
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Any mental disorder,50105,7969,0.92 [0.88-0.97],0.0006905016003413
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",51068,848,0.47 [0.41-0.55],8.51274291078232e-23
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",45294,3158,0.95 [0.88-1.03],0.2124445360813995
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",42314,178,0.82 [0.59-1.14],0.2391413944654359
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Smoking dependency,50340,2735,0.96 [0.88-1.04],0.3117357307197048
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",45393,3257,0.85 [0.79-0.92],2.537885601560445e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Vascular dementia,50384,250,1.04 [0.80-1.36],0.7539939735842016
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Alzheimer disease,51403,658,0.83 [0.70-0.98],0.0297779986907554
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",34640,118,1.25 [0.84-1.86],0.2677366072855406
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Bell's palsy,47857,160,1.19 [0.85-1.66],0.3132772189920064
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,48677,980,0.85 [0.74-0.97],0.0189988150475131
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Cerebral cysts,50581,458,1.23 [1.01-1.50],0.0442037988218075
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,51246,649,1.10 [0.93-1.30],0.267870963908099
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,50411,100,0.71 [0.46-1.11],0.1311057158587334
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,51372,120,1.08 [0.73-1.60],0.6821954975983788
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",50269,146,0.97 [0.68-1.39],0.8796823760931514
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Epilepsy,48287,573,0.79 [0.66-0.95],0.0107916294675457
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,50451,2737,1.06 [0.98-1.15],0.1718152043465376
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,51318,1197,0.86 [0.76-0.97],0.0167284583773457
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Falls/tendency to fall,50215,5130,0.95 [0.89-1.01],0.0822608918866657
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Generalized epilepsy,50642,106,0.73 [0.48-1.11],0.1362045038690406
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Hemiplegia,51106,509,1.23 [1.02-1.48],0.0282654150180042
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Hydrocephalus,50244,121,0.87 [0.59-1.28],0.4771363029373202
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,51369,134,1.51 [1.05-2.16],0.0254963344634781
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,47845,148,0.78 [0.54-1.12],0.1794239798065395
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,47861,164,0.88 [0.63-1.23],0.4419920345290072
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Memory loss,50099,214,0.79 [0.58-1.06],0.1122273465118938
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Migraine,48432,718,1.46 [1.24-1.71],4.298088951383739e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",51264,645,1.50 [1.27-1.77],2.131698170393846e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Motor neuron disease,34834,273,0.92 [0.71-1.21],0.5576452584592348
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,51073,206,1.31 [0.97-1.78],0.0760932178611571
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",50077,2380,0.94 [0.86-1.03],0.1748448624512091
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Neurological diseases,48465,7519,1.02 [0.97-1.07],0.4826815492553679
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,50706,395,0.84 [0.67-1.04],0.1018240156755943
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",48513,816,0.99 [0.85-1.15],0.902612480731869
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",51254,589,1.54 [1.30-1.83],6.742960666482816e-07
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,40871,1286,0.89 [0.79-1.01],0.0614556020880281
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,50273,150,0.78 [0.55-1.10],0.1583876885287696
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other disorders of nervous system,50403,280,1.12 [0.87-1.45],0.3621738638808151
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,50445,324,1.09 [0.86-1.38],0.4765245279807393
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other facial nerve disorders,47885,188,1.27 [0.93-1.72],0.1339918456753789
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other headache syndromes,47828,114,0.90 [0.60-1.35],0.6195855131963723
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other neurological diseases,51162,1039,1.07 [0.94-1.22],0.3025199455041164
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other sleep disorders,48825,1111,0.97 [0.85-1.10],0.6156969911922079
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Parkinson's disease,51357,848,0.79 [0.68-0.91],0.0015087262735153
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,50235,112,1.63 [1.09-2.44],0.016737543210703
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Restless leg syndrome,51403,149,1.18 [0.83-1.67],0.364810745811712
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Sleep apnoea,50921,954,0.93 [0.81-1.06],0.279495580361685
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Small fibre neuropathy,50763,98,1.48 [0.97-2.27],0.0703722045073075
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,51376,329,0.94 [0.74-1.20],0.6237407769244567
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,47798,101,1.69 [1.12-2.54],0.0124167324736138
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,51403,665,0.82 [0.69-0.97],0.0189373824994459
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),50309,243,1.08 [0.83-1.42],0.5667530064429414
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,50267,200,1.14 [0.84-1.55],0.3893458044419214
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,50586,787,0.95 [0.81-1.10],0.4804350740588426
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,51058,466,0.99 [0.82-1.20],0.9415091163222212
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,49409,106,0.86 [0.56-1.31],0.4730670128035614
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,49414,111,1.38 [0.92-2.07],0.1222210671794195
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",51189,106,1.03 [0.68-1.55],0.9047141233197672
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,50886,291,1.13 [0.88-1.45],0.3537401534921166
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",4172,120,3.43 [2.47-4.76],1.872624749384916e-13
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,5055,199,1.50 [1.14-1.99],0.0042410827499334
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,50253,186,1.04 [0.76-1.43],0.7981156542831283
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,50975,2066,0.95 [0.87-1.05],0.3315761399167922
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",50674,1371,0.92 [0.82-1.03],0.1412204753654806
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,49745,442,0.93 [0.76-1.14],0.4711806602007832
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",51233,1434,1.08 [0.96-1.21],0.2003155322559277
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,51384,134,1.15 [0.79-1.66],0.4641267521427875
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,51088,1289,1.05 [0.94-1.19],0.3872586207494368
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",51317,722,1.06 [0.90-1.24],0.4894003437862635
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,51216,357,0.91 [0.72-1.14],0.4049111440451665
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,49423,120,0.69 [0.46-1.02],0.0624516838608673
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,49438,135,0.89 [0.62-1.29],0.546885415333177
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,49411,108,0.85 [0.57-1.29],0.4576669110574269
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,51218,1405,0.96 [0.86-1.08],0.4807950569558993
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,50184,371,0.97 [0.77-1.21],0.7559362321076148
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,49896,97,0.95 [0.62-1.48],0.8324216456661533
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,50795,200,0.93 [0.69-1.26],0.6469277397626969
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,51132,537,1.12 [0.93-1.34],0.2466390832322683
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,50186,387,1.25 [1.00-1.55],0.0477581702723881
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,51079,220,0.97 [0.73-1.30],0.8355794906154903
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,50747,934,1.00 [0.87-1.15],0.9711764555311788
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,50347,280,1.14 [0.88-1.46],0.3243469060325772
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,48211,4318,0.97 [0.91-1.03],0.3095973572832406
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,51061,466,1.11 [0.91-1.36],0.2926339680556056
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,51363,303,1.24 [0.97-1.58],0.0861127350781066
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,50118,815,0.84 [0.73-0.98],0.0269656928331327
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,50724,129,1.09 [0.75-1.58],0.6572489160246714
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,51360,110,1.09 [0.72-1.63],0.6860323275755331
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,49469,166,1.12 [0.81-1.56],0.4963351565365158
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,49596,293,0.82 [0.63-1.05],0.1195818261966424
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,49143,234,0.98 [0.74-1.29],0.8709337031613187
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,49920,121,1.29 [0.87-1.90],0.2050652960892471
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",49031,122,0.77 [0.51-1.14],0.188608400938138
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,49984,171,0.93 [0.67-1.30],0.6755883685877226
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",50203,390,0.89 [0.72-1.10],0.2896417487577349
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,49556,253,0.91 [0.70-1.19],0.5055936726809489
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,49130,221,0.97 [0.72-1.31],0.8588646392907182
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,49078,169,0.79 [0.57-1.11],0.1733806999614485
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,47485,3592,1.03 [0.96-1.11],0.4114428846117628
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,49446,143,1.07 [0.75-1.52],0.7293195769643134
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,50893,826,1.04 [0.90-1.21],0.5842496849820571
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,50187,120,0.76 [0.52-1.12],0.1692196067289357
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),50403,336,1.32 [1.05-1.66],0.0175661079185652
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,50981,174,1.01 [0.73-1.39],0.975612637327905
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,51315,241,1.20 [0.92-1.59],0.1826997191549055
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,51147,253,1.13 [0.87-1.48],0.3629532103111166
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,50927,120,1.33 [0.90-1.95],0.1556704934446388
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,50932,125,1.22 [0.83-1.79],0.3107620673776481
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,51211,1781,1.04 [0.94-1.15],0.4560456888894293
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,50706,1276,1.07 [0.95-1.21],0.2775778317227886
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,49684,254,0.84 [0.64-1.10],0.2035636617435877
AGER,Advanced glycosylation end product-specific receptor,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,49599,169,1.06 [0.76-1.47],0.7373186424723566
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Acute pharyngitis,50917,150,1.24 [0.88-1.75],0.2249057441187917
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,51193,426,1.16 [0.94-1.42],0.1701336639994525
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,50893,126,1.42 [0.98-2.06],0.0641607352907881
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,All influenza,47375,237,1.25 [0.95-1.65],0.1111153319019118
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),47370,232,1.24 [0.94-1.64],0.1315138864477378
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Allergic asthma (mode),35226,234,0.87 [0.65-1.16],0.3364644488342481
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Allergic rhinitis,51137,555,0.91 [0.76-1.10],0.3286524071893595
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",37960,3507,0.89 [0.82-0.95],0.0015556253813019
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",38447,3455,0.88 [0.82-0.95],0.0015005048329433
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),50597,274,1.25 [0.97-1.61],0.0798588080416534
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",47300,162,1.27 [0.91-1.77],0.15931818662402
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Bronchiectasis,44565,698,0.68 [0.57-0.80],3.729817824907048e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",43980,113,1.08 [0.72-1.62],0.7188299028180409
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,49391,5524,0.81 [0.76-0.86],9.960743205659588e-13
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",48665,140,0.83 [0.57-1.20],0.3184500789402654
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Chronic sinusitis,48833,308,0.86 [0.67-1.10],0.2248802327555997
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",51002,2360,0.61 [0.56-0.67],3.0718334050191787e-27
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Deviated nasal septum,48737,212,1.18 [0.88-1.59],0.2753609344023393
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,47284,10440,0.95 [0.91-0.99],0.0107950389318034
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",49250,725,0.99 [0.84-1.16],0.8751560811375664
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Early onset COPD,49267,625,0.59 [0.49-0.70],6.263862486654751e-09
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Emphysema,44491,624,0.52 [0.44-0.62],1.1539870583555732e-13
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,48824,568,0.60 [0.50-0.72],4.3017297344950594e-08
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Influenza and pneumonia,50958,3820,0.98 [0.91-1.05],0.5407675995569787
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Interstitial lung disease,48894,638,0.69 [0.58-0.81],1.688870115345308e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Later onset COPD,49407,1735,0.61 [0.55-0.67],5.194144203712575e-21
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,51380,659,1.14 [0.97-1.34],0.1232417696803992
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Nasal polyp,48738,213,1.28 [0.96-1.72],0.0967800535902737
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,50907,1922,1.00 [0.91-1.11],0.9205689071554746
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other diseases of pleura,50932,3947,0.98 [0.92-1.05],0.5889670246541676
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,50186,1661,0.93 [0.83-1.03],0.1545378570590651
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other pleural conditions,47085,100,0.68 [0.44-1.06],0.0881750519307784
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,51227,795,0.86 [0.74-1.00],0.0435326094101749
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,51191,2568,0.89 [0.82-0.97],0.0058759878023439
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pleural effusion,48961,1976,1.17 [1.06-1.29],0.001423374112518
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pleural plaque,47295,310,0.90 [0.71-1.15],0.4116132790852176
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",50463,3325,0.95 [0.88-1.02],0.1609602089598394
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,51248,527,1.15 [0.95-1.38],0.1429856988804334
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pneumothorax,47216,231,0.86 [0.65-1.14],0.3008293528191887
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pollen allergy,51355,472,0.91 [0.74-1.11],0.3354240620519264
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pulmonary oedema,50562,130,2.09 [1.50-2.93],1.67246068004742e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Respiratory insufficiency,35101,109,0.55 [0.36-0.84],0.0054074264155072
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,50864,1879,1.00 [0.90-1.10],0.9505315540482132
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,49081,556,0.91 [0.75-1.09],0.3091785303942294
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Viral pneumonia,47632,494,1.15 [0.95-1.40],0.1461893827929087
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",50628,404,1.19 [0.96-1.46],0.1074955218092439
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,23700,227,0.86 [0.64-1.16],0.3238343192051467
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,36263,126,1.34 [0.92-1.96],0.1279288646610495
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Acute appendicitis,51080,288,0.87 [0.67-1.13],0.3104561238780773
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Acute gastritis,38654,181,1.42 [1.03-1.95],0.0305906669233096
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Acute pancreatitis,47721,366,1.11 [0.88-1.38],0.3777693318438671
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Acute peritonitis,50458,189,2.02 [1.51-2.70],2.0757391767307414e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Alcoholic liver disease,49615,150,0.68 [0.48-0.97],0.035598010808955
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Barrett oesophagus,39340,867,1.15 [0.99-1.34],0.0617023210997923
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",47555,200,1.32 [0.98-1.77],0.0716264511327892
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",50564,200,1.30 [0.96-1.74],0.0849489781534845
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Cholecystitis,47764,409,1.13 [0.91-1.39],0.2716505349094471
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Cholelithiasis,49340,1985,1.18 [1.07-1.30],0.0007273002555992
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Chronic gastritis,39082,609,1.29 [1.08-1.53],0.004621606515368
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Chronic pancreatitis,47454,99,0.96 [0.63-1.48],0.8644962628931133
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",51111,210,1.36 [1.02-1.81],0.0355859775835785
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Coeliac disease,48195,249,0.97 [0.73-1.28],0.8270643561146889
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Collagenous colitis,48038,161,1.07 [0.76-1.50],0.7160486861845491
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,51094,373,1.00 [0.80-1.25],0.9842730459033362
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Constipation,50890,3330,1.00 [0.93-1.08],0.9057966179644196
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Crohn disease,48064,187,1.26 [0.92-1.73],0.1440256923818412
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",50699,139,1.22 [0.85-1.76],0.2784088532315735
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Crohn's disease NAS,48054,177,1.60 [1.16-2.20],0.0037493937701745
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Dental caries,49922,463,1.00 [0.82-1.22],0.998823475936756
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,46150,4443,1.06 [0.99-1.13],0.0731242751321404
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of appendix,51154,362,0.82 [0.65-1.03],0.0857276854743874
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of liver,51162,1697,0.99 [0.89-1.10],0.8945959247976148
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",47095,8622,1.07 [1.02-1.12],0.0045823716960573
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",50572,1113,1.10 [0.97-1.25],0.1411696726751102
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of peritoneum,51230,961,1.27 [1.11-1.46],0.0006567566541919
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,49690,231,1.23 [0.93-1.63],0.1449746582761033
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of salivary glands,49390,133,0.99 [0.68-1.43],0.958381912929223
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of the digestive system,50784,2838,1.03 [0.95-1.12],0.4115585617807168
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of tongue,49422,219,1.16 [0.86-1.55],0.3304003945119539
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",50156,2801,1.14 [1.05-1.24],0.0012631210953948
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,42422,6285,0.96 [0.91-1.02],0.1613629313691348
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Duodenal ulcer,38870,397,1.03 [0.83-1.28],0.7707702118243169
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",51237,320,0.91 [0.72-1.16],0.4563995827804668
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,51226,107,0.93 [0.61-1.43],0.7476036253155397
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,49720,255,1.32 [1.01-1.71],0.0392137250505945
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,36431,294,1.10 [0.85-1.41],0.4756815496811121
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Functional dyspepsia,39563,1090,0.93 [0.81-1.06],0.2485249852895162
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastric ulcer,39187,714,1.24 [1.06-1.46],0.0076556433201942
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,43457,4984,1.00 [0.94-1.06],0.985180556495824
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,39540,1067,1.11 [0.98-1.27],0.1119869821485309
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,39760,16521,1.02 [0.98-1.05],0.3522219410098052
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,GI-bleeding,50271,2325,1.04 [0.95-1.14],0.3477646132461187
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,49569,110,1.07 [0.71-1.61],0.7550690864648661
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,38091,2514,1.03 [0.94-1.12],0.5006009750794977
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",49591,126,0.91 [0.62-1.33],0.6261347541442035
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Hernia,48159,6452,1.01 [0.96-1.06],0.7572697250054861
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Impacted teeth,51240,99,0.85 [0.55-1.33],0.4884566658990957
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Impaction of intestines,36246,109,1.55 [1.03-2.33],0.0345251953847847
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Inguinal hernia,43491,1784,0.91 [0.82-1.01],0.0765891330422043
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",41909,202,0.88 [0.65-1.21],0.4366607598606431
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,36329,192,0.93 [0.68-1.27],0.6581852405522912
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Intestinal malabsorption,48235,289,1.00 [0.77-1.30],0.9944934952988602
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,37240,1103,1.11 [0.98-1.27],0.111621984277357
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,51345,740,0.96 [0.82-1.13],0.6222018204716869
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,49389,1512,1.20 [1.08-1.34],0.0009527471308155
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,49884,2007,1.17 [1.06-1.28],0.0015284869938225
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Oesophageal obstruction,38849,376,1.05 [0.84-1.32],0.6529789436930729
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Oesophagitis,39679,1206,1.19 [1.05-1.35],0.0059868242547576
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,51306,275,0.90 [0.69-1.16],0.4110689708025402
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,41838,131,1.35 [0.93-1.95],0.1175066373721791
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,38849,2712,1.01 [0.93-1.10],0.7741266551581346
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,47918,563,1.13 [0.94-1.35],0.1884175647225647
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,47667,312,1.02 [0.80-1.30],0.8762576455267649
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of intestine,39624,3487,0.97 [0.91-1.05],0.4976639718029828
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of intestines,47376,11239,1.01 [0.97-1.05],0.6420786798140437
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,49380,416,0.87 [0.71-1.08],0.2156544103857056
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of liver,50853,1388,1.04 [0.93-1.17],0.4647116393573459
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,39794,1321,1.14 [1.01-1.29],0.0298666531539361
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of pancreas,47659,304,1.36 [1.07-1.73],0.0129917713533106
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,51091,822,1.18 [1.01-1.37],0.0329280219212782
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,40375,1902,1.17 [1.06-1.29],0.0018626679227881
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,50302,2356,1.04 [0.95-1.13],0.413008539059013
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,49836,377,1.11 [0.89-1.38],0.344840852834777
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,39561,3424,0.99 [0.92-1.06],0.7197100215708468
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),42485,4012,1.16 [1.09-1.24],1.2844856052276123e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,49665,200,1.10 [0.81-1.49],0.5451974909187166
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,49637,1760,1.20 [1.09-1.33],0.0003795443970046
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",36821,684,1.07 [0.91-1.26],0.411211072974604
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,51207,127,1.10 [0.74-1.62],0.6348169444122049
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,37112,975,1.01 [0.88-1.15],0.9423500434307714
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",48242,296,1.26 [0.99-1.62],0.0644320712032729
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Recurring oral aphthae,51383,113,1.28 [0.86-1.91],0.2254218819352772
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,49471,235,1.07 [0.81-1.42],0.6278145447838526
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Toxic colitis,47990,113,1.29 [0.87-1.92],0.2069941778161844
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,39010,537,0.99 [0.83-1.20],0.95411174692973
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Ulcerative colitis,48192,315,1.06 [0.83-1.36],0.6340412332119001
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",48139,262,1.03 [0.78-1.34],0.8568820982015858
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Umbilical hernia,42240,533,0.75 [0.62-0.90],0.0023353627076968
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,36489,352,1.09 [0.87-1.37],0.456640260796085
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Ventral hernia,42226,519,0.87 [0.72-1.05],0.1369370627005364
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Volvulus,36299,162,0.82 [0.58-1.16],0.2644666835025566
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,51239,592,1.19 [1.00-1.42],0.0552301404431273
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,50767,145,0.94 [0.66-1.35],0.7388112677322883
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,47323,321,1.04 [0.81-1.33],0.7512658558228205
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,50138,1407,1.14 [1.02-1.28],0.0200346900407135
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",49074,343,1.18 [0.94-1.49],0.1550924163767702
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,47813,811,1.15 [0.99-1.33],0.0658386731033888
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,50794,554,1.03 [0.86-1.23],0.7677051534860935
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,51205,965,1.16 [1.01-1.33],0.0314115630556994
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,50335,95,1.07 [0.69-1.68],0.7507413395760979
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,48304,6386,1.05 [0.99-1.10],0.0988570672639645
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,50502,890,1.01 [0.87-1.17],0.8891583523298768
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,50241,629,1.01 [0.85-1.20],0.87348070527028
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,50624,1893,1.13 [1.03-1.25],0.0116405987679403
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",51370,107,0.68 [0.44-1.03],0.0712337818325084
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,47116,114,0.64 [0.43-0.95],0.028550356557913
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,49714,102,1.03 [0.68-1.56],0.898650488536695
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,50774,534,1.02 [0.84-1.22],0.8660167893580122
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,47900,898,0.91 [0.79-1.05],0.2084078945837472
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,47131,129,1.29 [0.89-1.89],0.1814815493097399
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,51230,164,1.67 [1.21-2.30],0.0017290771872074
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,49107,376,1.16 [0.93-1.45],0.1798751657468506
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,51005,383,0.80 [0.64-1.00],0.0505805580148408
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,50370,130,1.85 [1.30-2.64],0.0006663991548327
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,47136,134,1.05 [0.72-1.53],0.7927158010773714
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,50252,3250,1.04 [0.97-1.12],0.2804915425289414
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",47975,973,0.92 [0.80-1.06],0.2554659466666896
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,47139,137,1.27 [0.88-1.83],0.205594928584241
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,51228,606,0.82 [0.69-0.98],0.0303323739857703
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,50380,140,1.44 [1.01-2.04],0.0414973842888652
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,51119,497,0.83 [0.68-1.01],0.0586917320484984
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,51295,648,1.15 [0.97-1.37],0.1007593206987797
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,47254,252,0.96 [0.73-1.27],0.7712710428445542
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,47540,538,1.03 [0.85-1.24],0.7903916839353651
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,51273,626,1.17 [0.99-1.40],0.0700235491861785
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",47475,473,1.29 [1.06-1.56],0.0091511784820076
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,51343,277,1.60 [1.25-2.06],0.0002189945200107
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,44114,216,0.97 [0.72-1.30],0.8291077442467161
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,46779,11218,0.98 [0.94-1.02],0.4028511228684982
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,43958,8397,0.95 [0.90-0.99],0.0236718267654554
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,44049,151,1.05 [0.73-1.49],0.8020096256343283
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,44571,304,1.09 [0.85-1.39],0.5076814476445017
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,44623,356,1.26 [1.01-1.58],0.0420909912323329
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,50907,182,1.04 [0.76-1.43],0.7999595935568853
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",44466,199,0.79 [0.58-1.08],0.1342832332060736
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,37812,2251,0.98 [0.89-1.07],0.6022861881870372
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",51132,367,1.02 [0.81-1.28],0.863987431350393
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,45158,891,0.82 [0.71-0.95],0.0091992067518568
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,43455,14443,0.96 [0.93-1.00],0.0285753834285719
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,47454,233,0.95 [0.72-1.27],0.7482606636848212
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,44201,303,1.03 [0.81-1.31],0.8184821544235005
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,45017,1119,0.95 [0.83-1.08],0.4070416201981724
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,49562,5295,0.97 [0.91-1.03],0.3174935097722796
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,44438,540,0.95 [0.79-1.15],0.589614962548261
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,44339,441,1.20 [0.97-1.47],0.0881757921614955
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,44162,264,1.01 [0.77-1.32],0.9483223131456064
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,50121,138,0.96 [0.67-1.39],0.8350002019662587
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,38916,3355,0.92 [0.85-0.99],0.0216477729916726
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,36774,1213,1.33 [1.18-1.51],3.144646105106503e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",51251,1196,1.33 [1.18-1.50],4.104305223448394e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,35710,149,0.76 [0.53-1.10],0.1442260900086734
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),36214,653,0.93 [0.78-1.10],0.3755263404379
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,44499,601,0.89 [0.74-1.06],0.1815234668813065
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,36825,1264,1.01 [0.90-1.15],0.8189055412969872
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,44377,110,1.18 [0.78-1.78],0.4227276573820288
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,45521,1254,1.03 [0.91-1.17],0.6054809310634471
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,44867,600,0.98 [0.82-1.17],0.8512037027633497
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,36739,1178,1.00 [0.88-1.13],0.9391849583544524
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,44056,158,1.18 [0.84-1.66],0.3466262463807632
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",44022,124,1.30 [0.89-1.90],0.1797254905558443
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,47362,141,0.90 [0.63-1.29],0.5720933113763967
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,50625,3404,0.92 [0.86-1.00],0.0385033960697121
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,49454,2233,0.91 [0.83-1.00],0.0554766376372776
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",51121,895,0.97 [0.84-1.12],0.6644489627704531
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,40523,4962,0.95 [0.89-1.01],0.0779845794785801
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,35687,126,1.00 [0.68-1.48],0.993476379126854
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,44084,186,1.03 [0.75-1.41],0.8753766158432944
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,35660,99,1.53 [1.00-2.34],0.0524709089743649
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),35812,251,0.85 [0.65-1.13],0.265321485568473
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,47700,479,1.06 [0.87-1.29],0.5478319392466062
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,47977,756,0.92 [0.78-1.07],0.2731676745532184
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,51338,197,1.37 [1.01-1.85],0.0419100280993122
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",47858,3591,1.02 [0.95-1.09],0.6052687588199892
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,44097,199,1.09 [0.80-1.48],0.5903244898238107
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),35833,272,1.03 [0.79-1.34],0.8458934296543343
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,45705,1438,1.03 [0.92-1.15],0.6571071367914152
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,39836,4275,1.02 [0.95-1.09],0.6466207356930094
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,50172,189,0.97 [0.71-1.32],0.8266493011531318
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,51368,139,0.89 [0.62-1.29],0.5543814379075893
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,44060,162,0.93 [0.67-1.31],0.6854201970829753
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",46386,2488,1.10 [1.01-1.20],0.0345761849060854
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,44078,180,1.26 [0.92-1.74],0.1473886801884318
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,38779,3218,1.03 [0.95-1.11],0.4954010175723458
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,47442,221,1.03 [0.77-1.37],0.8597736349314238
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,44006,108,0.79 [0.51-1.21],0.2729994913474765
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,44582,315,1.25 [0.99-1.59],0.0659181676404725
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,45002,1104,1.10 [0.97-1.25],0.1405684242128478
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,50686,703,0.85 [0.72-1.00],0.0547211996571292
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,45398,1131,1.14 [1.00-1.29],0.0435479246398943
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,51144,869,0.94 [0.81-1.09],0.4003328952021334
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,51360,108,1.03 [0.68-1.56],0.8738175716432226
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,44271,373,1.02 [0.81-1.28],0.8597261654356175
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,40680,1506,1.14 [1.02-1.27],0.0220617518288084
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,45054,1156,1.16 [1.02-1.31],0.0226226318496036
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],44349,451,0.88 [0.71-1.08],0.2224980701103935
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",35667,106,1.35 [0.89-2.05],0.1519496043880747
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,40505,4944,1.04 [0.98-1.11],0.1663022888810922
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,36871,1310,0.91 [0.80-1.02],0.1163599126327982
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,50441,458,0.82 [0.67-1.00],0.0523183464918934
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",51273,132,1.55 [1.08-2.24],0.0184754073492336
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",47094,101,1.09 [0.72-1.65],0.6691512198789329
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,35703,142,0.89 [0.61-1.29],0.5317183175997371
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,44466,199,0.78 [0.57-1.06],0.1138179106210941
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,36467,906,0.96 [0.83-1.11],0.5898003535929728
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,44516,618,0.99 [0.83-1.18],0.9185402088359184
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,44773,506,0.94 [0.78-1.14],0.5352128749840139
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,44644,377,0.76 [0.60-0.95],0.0149448557247239
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,40198,116,0.93 [0.62-1.39],0.7282004551195231
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",51367,115,1.05 [0.71-1.57],0.80323835413508
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,45068,1170,0.94 [0.83-1.07],0.3388637278102827
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],50169,186,1.15 [0.84-1.57],0.3934909391017633
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,49009,5111,1.02 [0.96-1.08],0.6123519038984654
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",44158,260,0.80 [0.61-1.05],0.1032988136804245
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,45356,1089,0.96 [0.84-1.10],0.563131077959399
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,48600,468,1.13 [0.93-1.37],0.2328351517028844
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,44682,415,0.88 [0.71-1.09],0.2454605587365028
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,47363,3096,1.02 [0.94-1.10],0.6192014970151254
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,46293,2026,1.03 [0.93-1.13],0.5686434120888875
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],44006,108,1.07 [0.71-1.62],0.7386398985869602
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,50250,267,0.95 [0.73-1.23],0.6942995142729915
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,44221,323,0.99 [0.77-1.26],0.9091564270860414
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,44048,150,0.79 [0.55-1.12],0.1865108562127701
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),35674,113,1.20 [0.80-1.79],0.3859529569993933
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Acute renal failure,49298,3142,1.50 [1.39-1.62],5.133690819167736e-26
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20771,102,0.89 [0.58-1.38],0.6037370899853185
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27026,111,1.10 [0.73-1.67],0.6374731256584596
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,50766,641,1.16 [0.98-1.37],0.0921195741060243
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,50288,163,0.81 [0.58-1.14],0.2273879267331846
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,49219,3063,2.59 [2.41-2.78],1.7855531691503249e-150
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,50974,168,4.50 [3.66-5.54],4.288080654909097e-46
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,50909,608,1.35 [1.14-1.60],0.0005786438285516
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Cystitis,45271,466,1.15 [0.94-1.40],0.1800820925115675
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Dialysis,46316,160,1.91 [1.36-2.68],0.000197619401402
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,22385,3291,1.05 [0.97-1.13],0.2078719651193064
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27258,343,0.94 [0.74-1.18],0.5768859589772204
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Endometriosis,20850,181,0.81 [0.58-1.12],0.2059360974948715
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21070,401,0.87 [0.69-1.09],0.2198799669539209
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21688,1019,0.88 [0.76-1.01],0.0599064232245577
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,42894,10692,1.11 [1.07-1.16],1.043792380408476e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,50974,168,2.81 [2.14-3.70],1.606417207219118e-13
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Hydrocele,19300,206,1.03 [0.76-1.38],0.8711907432568083
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,46139,586,1.21 [1.01-1.45],0.0428874696041565
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21688,2594,1.08 [0.99-1.18],0.0662058184284271
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27186,403,0.88 [0.71-1.09],0.2419221983248415
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19324,230,1.02 [0.77-1.35],0.9033679935876848
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Irregular menses,27269,129,0.93 [0.63-1.37],0.7042349532240822
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Menorrhagia,20977,308,0.88 [0.69-1.14],0.3454801267062596
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,44960,155,1.52 [1.08-2.14],0.0167373347368156
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,23149,2480,0.88 [0.80-0.96],0.0038731361728641
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,19201,107,1.30 [0.87-1.95],0.2049171809636506
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20808,139,1.16 [0.80-1.67],0.4418244490476456
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",51379,129,1.39 [0.96-2.00],0.0831149419452984
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",51386,134,0.96 [0.66-1.39],0.8370128365606857
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,49308,4503,1.10 [1.03-1.17],0.0043837880132376
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,46234,1429,1.05 [0.94-1.18],0.3964277391444885
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27036,121,0.84 [0.56-1.24],0.3805727785180681
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,51263,962,1.65 [1.45-1.89],1.2945166399951474e-13
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19400,306,1.16 [0.91-1.49],0.2304652506618902
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19368,274,1.17 [0.90-1.51],0.2443225444599793
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,19323,229,1.06 [0.80-1.41],0.6759714647321289
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,51326,141,1.64 [1.16-2.33],0.0055679994343314
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,48274,3469,1.13 [1.05-1.21],0.0014226019306795
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,26991,208,1.03 [0.76-1.39],0.8506227256911243
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20827,158,0.85 [0.60-1.20],0.3488578731983148
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21041,372,0.92 [0.74-1.15],0.4733825588016942
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20780,111,0.67 [0.44-1.02],0.0645271524547303
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20880,211,0.83 [0.61-1.12],0.2121063019229418
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,46236,683,1.38 [1.17-1.63],0.0001666181811636
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,50618,317,1.94 [1.55-2.44],1.0123511630111106e-08
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,20977,308,0.91 [0.71-1.16],0.438194213447494
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20775,106,0.59 [0.38-0.91],0.0165064997791174
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21321,652,0.95 [0.80-1.13],0.5667887061597061
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,20831,162,0.68 [0.48-0.95],0.0262900497185952
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21271,602,1.06 [0.89-1.27],0.4894955655008061
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,50904,98,2.35 [1.58-3.49],2.176431234787421e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19355,261,1.25 [0.96-1.62],0.1006850167053078
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,50902,5349,1.64 [1.55-1.74],4.627473076231448e-63
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",45792,239,1.42 [1.07-1.88],0.0154997164323152
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,46418,262,3.01 [2.37-3.81],7.947880487258319e-20
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,50238,113,1.55 [1.05-2.30],0.02746736341394
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Urethral stricture,45245,440,1.27 [1.04-1.56],0.0196715593947076
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Urolithiasis,50918,793,1.12 [0.96-1.31],0.1338598333406893
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20812,143,1.04 [0.72-1.50],0.8380168467302266
